Report on EU-X-CT public stakeholder meeting
The pan-European public-private EU-X-CT initiative aims to facilitate cross-border access to clinical trials. As a first step, EU-X-CT is collecting information on the regulatory, ethical, social security, liability insurance and organisational conditions for the involved stakeholders, as well as experiences and best practices in all European countries.
At the Public Stakeholders’ Forum held in Brussels on April 12, 2024, the national conditions for patients, clinical investigators, academia/public funders, and industry sponsors needing cross-border participation of patients in clinical trials were reviewed including participation from ECRIN's Director General, Jacques Demotes. The EU-X-CT leadership presented the initial results of the EU-X-CT gap analysis.
This report summarises key insights from the meeting:
